Analyst Sam Eiber of BTIG maintained a Buy rating on Establishment Labs Holdings (ESTA – Research Report), retaining the price target of $62.00.
Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Sam Eiber’s rating is based on several key factors that highlight the growth potential and strategic positioning of Establishment Labs Holdings. The company is poised for significant expansion with the U.S. launch of its Motiva product line, which is expected to capture a substantial market share in the breast augmentation sector. Management’s forecast of over 20% annual growth for the next three years and achieving cash flow positivity by 2026 underscores a robust financial outlook.
Furthermore, the company’s innovation pipeline and the anticipated introduction of minimally invasive products are likely to expand its market reach. The progress of the U.S. Motiva launch, with over 900 accounts onboarded and a high reorder rate, indicates strong demand and successful market penetration. These strategic initiatives, coupled with a favorable valuation based on revenue estimates, support the Buy rating assigned by Sam Eiber.